We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Stock Exchanges to Halt Trading of Elan During FDA's Tysabri Review
Stock Exchanges to Halt Trading of Elan During FDA's Tysabri Review
March 3, 2006
Stock exchanges in the UK, Ireland and New York will suspend trading shares of Irish drug firm Elan while an FDA advisory committee reviews Elan’s multiple sclerosis drug Tysabri, Elan said Feb. 28.